Integral Health Asset Management, LLC I Teos Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$13.02 - $22.62 $1.17 Million - $2.04 Million	-90,000 Reduced 33.33%	180,000 $2.45 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $1.33 Million - $1.62 Million	75,000 Added 38.46%	270,000 $5.27 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $715,114 - $1.05 Million	38,447 Added 24.56%	195,000 $3.72 Million
Q2 2022 Aug 03, 2022	BUY	$16.57 - $35.1 $1.19 Million - $2.51 Million	71,553 Added 84.18%	156,553 $3.23 Million
Q1 2022 May 12, 2022	BUY	$31.92 - $47.45 $1.12 Million - $1.66 Million	35,000 Added 70.0%	85,000 $2.74 Million
Q4 2021 Feb 02, 2022	BUY	$26.23 - $47.86 $1.31 Million - $2.39 Million	50,000 New	50,000 $2.33 Million

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.